Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) Restructuring Costs (2016 - 2025)

Healthstream (HSTM) has disclosed Restructuring Costs for 12 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Restructuring Costs rose 6.42% to $9.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.8 million, a 6.73% decrease, with the full-year FY2025 number at $32.8 million, down 6.73% from a year prior.
  • Restructuring Costs was $9.4 million for Q4 2025 at Healthstream, up from $7.3 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $10.2 million in Q4 2021 to a low of $7.3 million in Q3 2025.
  • A 5-year average of $9.0 million and a median of $9.1 million in 2022 define the central range for Restructuring Costs.
  • Biggest YoY gain for Restructuring Costs was 6.42% in 2025; the steepest drop was 22.59% in 2025.
  • Healthstream's Restructuring Costs stood at $10.2 million in 2021, then dropped by 12.1% to $9.0 million in 2022, then fell by 6.32% to $8.4 million in 2023, then grew by 4.34% to $8.8 million in 2024, then grew by 6.42% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Restructuring Costs are $9.4 million (Q4 2025), $7.3 million (Q3 2025), and $7.4 million (Q2 2025).